Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jing Xi MD, MPH

Jing Xi MD, MPH

Breast Oncologist, Rocky Mountain Cancer Centers, Denver, Colorado

Dr. Jing Xi is a breast oncologist at Rocky Mountain Cancer Centers in Denver, Colorado. She maintains an active research focus in breast oncology. She is the principle investigator for multiple multicenter breast cancer clinical trials. She has first-authored research articles in peer-reviewed journals and presented her research at national oncology conferences, including the American Society of Clinical Oncology (ASCO) and the San Antonio Breast Cancer Symposium (SABCS). She also serves as the editorial board member for Journal of Clinical Oncology Oncology Practice.

She is an active member of ASCO, the American Society of Hematology (ASH), and the American Association of Cancer Research (AACR). She is also a member of the Chinese American Hematology and Oncology Network (CAHON), which awarded her a Young Investigator Award (YIA) in 2020 and 2021.

Dr. Xi received her MD from Fudan University in Shanghai, China, and her MPH from the University of Michigan, Ann Arbor, MI. She underwent residency training in internal medicine at St. Luke’s Hospital in Chesterfield, Missouri, where she served as Chief Resident in 2018–2019. She completed her hematology and oncology fellowship at Washington University in St. Louis, Missouri.